More from KUOW Health Seattle Biotech Company Dendreon Files For Bankruptcy KUOW | By Ross Reynolds, Amina Al-Sadi Published November 10, 2014 at 1:29 PM AKST Twitter LinkedIn Email Listen • 4:31 Ross Reynolds talks to Seattle biotech writer Luke Timmerman about the biotech company Dendreon, which filed for bankruptcy after their prostate cancer drug failed to make a sizable profit.